Price Alert

Medpace Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

458.44

-9.56 (-2.04%)

At close: Aug 14, 2025, 3:59 PM

455.50

-0.64%

After-hours: Aug 14, 2025, 05:04 PM EDT

-2.04% (1D)

Bid	439.04
Market Cap	12.88B
Revenue (ttm)	2.23B
Net Income (ttm)	418.3M
EPS (ttm)	13.48
PE Ratio (ttm)	34.01
Forward PE	28.05
Analyst	Hold

Ask	471
Volume	316,556
Avg. Volume (20D)	498,924
Open	460.83
Previous Close	468.00
Day's Range	456.07 - 468.17
52-Week Range	250.05 - 501.30
Beta	1.43

About MEDP

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MEDP

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MEDP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Medpace Inc. is scheduled to release its earnings on Oct 20, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

-1.13%

Medpace Holdings shares are trading lower after UB... Unlock content with Pro Subscription

3 weeks ago

-0.96%

Medpace Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance above estimates.

News

1 week ago · seekingalpha.com

Medpace: Return Of The Mack, With Double-Digit Revenue Growth

Medpace delivered a stunning Q2 2025, with double-digit revenue and net new awards growth, defying widespread healthcare sector pessimism. The company achieved 14% YoY revenue growth and 18.6% EBITDA ...

2 weeks ago · zacks.com

Should You Buy Medpace (MEDP) After Golden Cross?

After reaching an important support level, Medpace Holdings, Inc. (MEDP) could be a good stock pick from a technical perspective. MEDP recently experienced a "golden cross" event, which saw its 50-day...

2 weeks ago · zacks.com

What Makes Medpace (MEDP) a New Strong Buy Stock

Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

2 weeks ago · zacks.com

Best Momentum Stocks to Buy for July 28th

CALX, MEDP and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2025.

2 weeks ago · zacks.com

New Strong Buy Stocks for July 28th

MEDP, CBFV, CALX, TREE and HAS have been added to the Zacks Rank #1 (Strong Buy) List on July 28, 2025.

3 weeks ago · zacks.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

3 weeks ago · fool.com

Medpace Beats Q2 Revenue Estimates

Medpace (MEDP 54.51%), a clinical contract research organization that manages drug development for pharmaceutical and biotech clients, reported its second quarter 2025 earnings on July 17, 2025. The c...

3 weeks ago · seekingalpha.com

Medpace Holdings, Inc. (MEDP) Q2 2025 Earnings Call Transcript

Medpace Holdings, Inc. (NASDAQ:MEDP ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants August James Troendle - Chairman & CEO Jesse J. Geiger - President Kevin M.